Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0288-2021

Drug recall · March 3, 2021

Fludeoxyglucose F 18 Injection recall

Why: Lack of Assurance of Sterility

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50

Lots / codes

Lot # P01-021721, exp 02/17/2021

Quantity
50 mL vial
Company
The General Hospital Corporation, Boston, MA
Distribution
Product was distributed to one direct account.
Initiated
February 17, 2021 · Voluntary: Firm initiated
Classified
February 24, 2021
Reported
March 3, 2021
Ended
March 26, 2021
How notified
Telephone

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.